Literature DB >> 2079655

Stability of ribonuclease A in solution and the freeze-dried state.

M W Townsend1, P P DeLuca.   

Abstract

The solution stability of bovine pancreatic ribonuclease A (RNase) in phosphate buffer (pH 4.0, 6.4, and 10.0) at 45 degrees C decreased with increasing pH. Soluble aggregates were formed at each pH and corresponded qualitatively to the loss of enzymatic activity in the samples. Freeze drying of RNase resulted in no immediate loss of enzymatic activity in both the presence and absence of phosphate buffer salts. Freeze-dried RNase stored at 45 degrees C lost enzymatic activity and formed nondissociable aggregates at rates described by the following rank order of formulation contents: distilled water less than pH 6.4 phosphate buffer, less than pH 4.0 phosphate buffer less than pH 10.0 phosphate buffer. The amount of residual moisture remaining in the freeze-dried cakes was directly related to the rate of enzymatic activity loss and aggregate formation. The degradation rate was also directly related to the concentration of phosphate buffer salts added to the freeze-dried formulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2079655     DOI: 10.1002/jps.2600791209

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

Review 1.  Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation.

Authors:  Eva Y Chi; Sampathkumar Krishnan; Theodore W Randolph; John F Carpenter
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

2.  Long-term and high-temperature storage of supercritically-processed microparticulate protein powders.

Authors:  M A Winters; P G Debenedetti; J Carey; H G Sparks; S U Sane; T M Przybycien
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

3.  Stability of beta-galactosidase, a model protein drug, is related to water mobility as measured by 17O nuclear magnetic resonance (NMR).

Authors:  S Yoshioka; Y Aso; K Izutsu; T Terao
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

4.  Effect of benzyl alcohol on recombinant human interleukin-1 receptor antagonist structure and hydrogen-deuterium exchange.

Authors:  John R Alford; Andrew C Fowler; Deborah S Wuttke; Bruce A Kerwin; Ramil F Latypov; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2011-05-05       Impact factor: 3.534

5.  Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra.

Authors:  Gerald S Baron; Andrew G Hughson; Gregory J Raymond; Danielle K Offerdahl; Kelly A Barton; Lynne D Raymond; David W Dorward; Byron Caughey
Journal:  Biochemistry       Date:  2011-05-03       Impact factor: 3.162

6.  Aggregates formed during storage of beta-galactosidase in solution and in the freeze-dried state.

Authors:  S Yoshioka; Y Aso; K Izutsu; T Terao
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

7.  Surface denaturation at solid-void interface--a possible pathway by which opalescent particulates form during the storage of lyophilized tissue-type plasminogen activator at high temperatures.

Authors:  C C Hsu; H M Nguyen; D A Yeung; D A Brooks; G S Koe; T A Bewley; R Pearlman
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

8.  Studies towards the stabilisation of a mushroom phytase produced by submerged cultivation.

Authors:  Michele Rigon Spier; Diana Behsnilian; Acácio Zielinski; Ursula Konietzny; Ralf Greiner
Journal:  Protein J       Date:  2015-10       Impact factor: 2.371

9.  Selective porous gates made from colloidal silica nanoparticles.

Authors:  Roberto Nisticò; Paola Avetta; Paola Calza; Debora Fabbri; Giuliana Magnacca; Dominique Scalarone
Journal:  Beilstein J Nanotechnol       Date:  2015-11-04       Impact factor: 3.649

Review 10.  Immunogenicity of therapeutic proteins: influence of aggregation.

Authors:  Kirsty D Ratanji; Jeremy P Derrick; Rebecca J Dearman; Ian Kimber
Journal:  J Immunotoxicol       Date:  2013-08-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.